GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

People taking GLP-1 drugs had a 14% lower risk of experiencing a major heart event compared to those on a placebo. The benefits extended across the board: fewer deaths overall, fewer non-fatal heart ...

A new study is showing GLP-1 drugs like Ozempic and Wegovy may trigger temporary hair loss, and researchers say these ...

A recently published study found that social judgments extend beyond whether you lose weight or not, but also to how you do ...

A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...

After accounting for 14% of all prescription drug spending in 2025, the blockbuster GLP-1 drug class is on track to continue rapid growth and alter pharmaceutical spending trends.  For example, Eli ...

The Medicare GLP-1 Bridge will provide eligible Medicare beneficiaries living with obesity access to Wegovy® (semaglutide) injection and tablets for a $50 monthly copay†, beginning July 1, 2026, per ...

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a ...

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

New research may help ease concerns about the effect of drugs like Ozempic on muscles while also underscoring the importance ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

Marico's India revenue share of the foods and premium personal care portfolios (including digital-first brands ) stood at ~23 ...